Your browser doesn't support javascript.
loading
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs.
Neogi, Ujjwal; Hill, Kyle J; Ambikan, Anoop T; Heng, Xiao; Quinn, Thomas P; Byrareddy, Siddappa N; Sönnerborg, Anders; Sarafianos, Stefan G; Singh, Kamal.
Affiliation
  • Neogi U; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, 14186 Stockholm, Sweden.
  • Hill KJ; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65211, USA.
  • Ambikan AT; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65211, USA.
  • Heng X; Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA.
  • Quinn TP; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, 14186 Stockholm, Sweden.
  • Byrareddy SN; Department of Biochemistry, University of Missouri, Columbia, MO 65211, USA.
  • Sönnerborg A; Department of Biochemistry, University of Missouri, Columbia, MO 65211, USA.
  • Sarafianos SG; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Centre, Omaha, NE 68198, USA.
  • Singh K; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65211, USA.
Pathogens ; 9(5)2020 Apr 26.
Article in En | MEDLINE | ID: mdl-32357471
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pathogens Year: 2020 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pathogens Year: 2020 Type: Article Affiliation country: Sweden